INS and metabolic syndrome: Insulin resistance, a condition observed in metabolic syndrome and T2DM and implicated in cardiometabolic disorders, is characterized by the impairment of insulin-triggered signaling pathways, which leads to disturbances in the insulin-controlled metabolism of carbohydrates and lipids, as well as endothelial dysfunction.